5-Diazacycloalkyl imidazo[1,2-c][1,3]benzodiazepines

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

260239BC, 2602433, 2602456, 2604537, 260464, 424273R, 544229, 544370, 548335, 548342, 548343, 564254, A61K 31415, C07D48704

Patent

active

044605870

ABSTRACT:
5-Diazacycloalkylimidazo[1,2-c][1,3]benzodiazepines, for example compounds of the formula ##STR1## in which e.g., R.sub.1, R.sub.2 and R.sub.4 are hydrogen, R.sub.3 is methyl and C.sub.n H.sub.2n is CH.sub.2 CH.sub.2, have neuroleptic and/or antihistaminic activity. The synthesis, pharmaceutical compositions and methods of treatment utilizing such compounds are described.

REFERENCES:
patent: 3539573 (1970-11-01), Schmutz et al.
patent: 3933794 (1976-01-01), Hester, Jr. et al.
patent: 4192803 (1980-03-01), Wright et al.
patent: 4280957 (1981-07-01), Walser et al.
patent: 4337198 (1982-06-01), Sorg et al.
patent: 4391808 (1983-07-01), Vlattas
William B. Wright, Jr. et al., Derivatives of 11[1-piperazinyl]-5H-Pyrrolo[2,1-c][1,4]Benzodiazepine as Central Nervous System Agents, J. Med. Chem., 1980, 23, 462-465.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

5-Diazacycloalkyl imidazo[1,2-c][1,3]benzodiazepines does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 5-Diazacycloalkyl imidazo[1,2-c][1,3]benzodiazepines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 5-Diazacycloalkyl imidazo[1,2-c][1,3]benzodiazepines will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1490616

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.